neurothrombectomy

neurothrombectomy

(noor″ō-throm-bek′tŏ-mē, nūr″) [ neuro- + thrombectomy ]
The surgical removal of a blood clot from a blood vessel in the brain. It is used to treat acute ischemic stroke.
References in periodicals archive ?
com)-- Vesalio announces the CE Mark certification of its first product line, the proprietary NeVa[TM] neurothrombectomy platform for the treatment of strokes.
In this report, the global neurovascular devices/interventional neurology market is segmented on the basis of technology (embolization & coiling, carotid artery angioplasty & stenting, supporting techniques, and neurothrombectomy) and product (cerebral balloon angioplasty & stenting systems, aneurysm coiling & embolization devices, support devices, and neurothrombectomy devices).
The neurointerventional device market encompasses neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire).
On the basis of product type the Interventional Neurology Devices market is segmented into aneurism coiling and embolization devices, angioplasty devices, neurothrombectomy devices and, micro support devices.
Meanwhile, novel reperfusion strategies such as Cerevast's ClotBust ER Sonolysis Headframe System, CoAxia's NeuroFlo and BrainsGate's Ischemic Stroke System, offer unique non-pharmacological approaches alongside currently-approved neurothrombectomy devices from companies like Concentric Medical, Penumbra and ev3.
Europe Spinal implants are segmented by product type, into aneurism coiling and embolization devices, angioplasty devices, neurothrombectomy devices and, micro support devices.
Recently released results from the CREST trial coupled with the approval of hemodynamic repair devices in the US and expansion of neurothrombectomy devices into international markets will fuel growth.
On the basis of product the interventional neurology devices market is segmented into aneurism coiling and embolization devices, angioplasty devices, neurothrombectomy devices and, micro support devices.
Reverse Medical Corporation announced today that it has received US Food and Drug Administration (FDA) conditional approval to begin a neurothrombectomy IDE study for its ReStore[TM] Microcatheter at twenty US centers.
Commenting on this regulatory approval, Reverse Medical's Chief Executive Officer Jeffrey Valko said, "The Reverse Medical ReStore[TM] Microcatheter offers the physician three progressive therapeutic options from one device, aimed to optimize acute ischemic stroke patient outcomes: 1) rapid blood flow restoration, 2) direct infusion into the clot, and 3) neurothrombectomy.
Among product types, embolic coils product segment is expected to dominate the global neurointerventional devices market, followed by the neurothrombectomy product segment.